At its CES exposition, AMD demonstrated its latest Instinct MI325X accelerator for AI and HPC workloads, which also happens ...

Advanced Micro Devices' stock price fell to new 52-week lows. Click here to find out the factors that present a strong buying ...

Absci will use AMD’s $20 million investment to enhance its AI models. In parallel, the companies will collaborate to develop ...

AI drug creation company Absci Corporation (NASDAQ:ABSI) shares are trading higher in premarket on Wednesday after the ...

We recently compiled a list of the 7 Best Semiconductor Stocks to Buy Now. In this article, we are going to take a look at ...

The Hunter supercomputer is ready for use in Stuttgart. It primarily uses AMD's Instinct MI300A combined processor.

Wednesday has announced a strategic collaboration with AMD to deploy AMD Instinct accelerators and ROCm software to support critical AI-driven drug discovery tasks, including Absci's advanced de ...

Absci Corporation (ABSI) announced a strategic collaboration with AMD (AMD) to deploy AMD Instinct accelerators and ROCm software to power critical AI drug discovery workloads, including Absci’s ...

At its CES exposition, AMD demonstrated its latest Instinct MI325X accelerator for AI and HPC workloads, which also happens to be the world's only processor with 256 GB of HBM3E memory onboard and ...

Absci Corporation (ABSI), a Washington-based biotechnology company, Wednesday has announced a strategic collaboration with AMD to ...

AMD makes a $20 million investment to boost drug research. The partnership will leverage AMD Instinct accelerators and ROCm software to support Absci’s advanced de novo antibody design models.

The partnership will leverage AMD Instinct accelerators and ROCm software to support Absci’s advanced de novo antibody design models. The deal also includes a $20 million private investment in ...